EDSA
NASDAQ
$5.82
Edesa Biotech Inc (EDSA)
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development, manufacture and marketing of pharmaceuticals for inflammatory and immune-related diseases. The company is headquartered in Markham, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $16.33 (+180.58%)
Market Cap
$61M
Free Cash Flow Yield
-12.33%
Beta (5Y)
0.13
Price Chart
Valuation
Market Cap$61M
Forward P/E0.18
P/S130462.29
P/B35.63
Profitability
Gross Profit (TTM)$311K
EBITDA-$11M
EPS-$1.31
Financial Health
Free Cash Flow Yield-12.33%
Growth & Risk
EPS 5Y CAGR+9.14%
FCF 5Y CAGR-10.66%
Beta (5Y)0.13
Sharpe Ratio1.21